乳酸正常合并代谢性酸中毒的SAKI患者的预后分析

陈筱岚, 陈晨, 田磊, 等. 乳酸正常合并代谢性酸中毒的SAKI患者的预后分析[J]. 临床急诊杂志, 2021, 22(7): 469-472. doi: 10.13201/j.issn.1009-5918.2021.07.006
引用本文: 陈筱岚, 陈晨, 田磊, 等. 乳酸正常合并代谢性酸中毒的SAKI患者的预后分析[J]. 临床急诊杂志, 2021, 22(7): 469-472. doi: 10.13201/j.issn.1009-5918.2021.07.006
CHEN Xiaolan, CHEN Chen, TIAN Lei, et al. Prognosis of SAKI patients with normal lactic acid and metabolic acidosis[J]. J Clin Emerg, 2021, 22(7): 469-472. doi: 10.13201/j.issn.1009-5918.2021.07.006
Citation: CHEN Xiaolan, CHEN Chen, TIAN Lei, et al. Prognosis of SAKI patients with normal lactic acid and metabolic acidosis[J]. J Clin Emerg, 2021, 22(7): 469-472. doi: 10.13201/j.issn.1009-5918.2021.07.006

乳酸正常合并代谢性酸中毒的SAKI患者的预后分析

  • 基金项目:

    国家自然科学基金面上项目(No:81671881)

详细信息
    通讯作者: 朱长清,E-mail:zhucq1965@126.com
  • 中图分类号: R631.2

Prognosis of SAKI patients with normal lactic acid and metabolic acidosis

More Information
  • 目的:探讨乳酸水平正常但合并代谢性酸中毒的脓毒症致急性肾损伤(SAKI)患者的预后。方法:2014年1月1日—2018年12月31日期间共有319例脓毒症患者收住于上海交通大学医学院附属仁济医院急诊ICU,根据所有患者入院首次、48 h、7 d的肌酐及每小时尿量和AKI定义将197例SAKI患者纳入本研究,记录其入院首次动脉血气分析结果(pH、Lac、HCO3-、BE);根据28 d死亡与否分为生存组和死亡组,并比较两组患者一般资料及Lac值;进一步筛选出Lac≤2 mmol/L的SAKI患者,比较这部分Lac正常的SAKI患者血气中pH、HCO3-、BE对其28 d病死率的预测价值。结果:197例SAKI患者28 d病死率为37.7%(51/197),死亡组Lac值较生存组明显升高[2.2(1.3,3.2) mmol/L vs.1.5(1,2.35) mmol/L,P=0.002]。但其中有120例患者Lac≤2 mmol/L,Lac正常的SAKI患者病死率为18.3%(22/120);与生存组相比较,死亡的22例患者pH<7.35、BE<-3 mmol/L的比例明显增高(45.5%vs.11.2%、64.6%vs. 33.7%,均P<0.05);BE联合pH值预测Lac≤2 mmol/L的SAKI患者28 d死亡的AUC为0.744,敏感度为81.82%,特异度为69.39%。结论:SAKI患者死亡组血气Lac值明显增高,但Lac水平正常的SAKI患者出现代谢性酸中毒时仍有较高的病死率,其中pH联合BE预测Lac正常的SAKI患者的28 d病死率效能最佳。
  • 加载中
  • [1]

    Singer M,Deutschman CS,Seymour CW,et al,The third international consensus definitions for sepsis and septic shock(sepsis-3) [J].JAMA,2016,315(8):801-810.

    [2]

    van Gestel A,Bakker J,Veraart CP,et al.Prevalence and incidence of severe sepsis in Dutch intensive care units[J].Crit Care,2004,8(4):R153-162.

    [3]

    Silva E,Pedro Mde A,Sogayar AC,et al.Brazilian Sepsis Epidemiological Study(BASES study)[J].Crit Care,2004,8(4):R251-260.

    [4]

    Linde-Zwirble WT,Angus DC.Severe sepsis epidemiology:sampling,selection,and society[J].Crit Care,2004,8(4):222-226.

    [5]

    Bushinsky DA,Coe FL,Katzenberg C,et al.Arterial PCO2 in chronic metabolic acidosis[J].Kidney Int,1982,22(3):311-314.

    [6]

    Levy MM,Evans LE,Rhodes A.The surviving sepsis campaign bundle:2018 update[J].Intensive Care Med,2018,44(6):925-928.

    [7]

    Mitra B,Roman C,Charters KE,et al.Lactate,bicarbonate and anion gap for evaluation of patients presenting with sepsis to the emergency department:A prospective cohort study[J].Emerg Med Australas,2020,32(1):20-24.

    [8]

    Bellomo R,Ronco C,Kellum JA,et al.Acute renal failure-definition,outcome measures,animal models,fluid therapy and information technology needs:the Second International Consensus Conference of the Acute Dialysis Quality Initiative(ADQI)Group[J].Crit Care,2004,8(4):R204-212.

    [9]

    Bagshaw SM,George C,Bellomo R,et al.Early acute kidney injury and sepsis:a multicentre evaluation[J].Crit Care,2008,12(2):R47.

    [10]

    Briguori C,Donnarumma E,Quintavalle C,et al.Contrast-induced acute kidney injury:potential new strategies[J].Curr Opin Nephrol Hypertens,2015,24(2):145-153.

    [11]

    Kraut JA,Kurtz I.Metabolic acidosis of CKD:Diagnosis,clinical characteristics,and treatment[J].Am J Kidney Dis,2005,45(6):978-993.

    [12]

    Samanta S,Singh RK,Baronia AK,et al.Early pH Change Predicts Intensive Care Unit Mortality[J].Indian J Crit Care Med,2018,22(10):697-705.

  • 加载中
计量
  • 文章访问数:  170
  • PDF下载数:  36
  • 施引文献:  0
出版历程
收稿日期:  2020-11-20

目录